Concurrently, R848 self-assembled nanoparticles have emerged as potent immunomodulators, significantly enhancing anti-tumor immunity by synergistically activating TLR7/8 pathways and re-polarizing tumor-associated macrophages [31]. The gene discussed is TLR7; the disease is neoplasm.